Artemether + Lumefantrine

Welcome to Dwaey, specifically on Artemether + Lumefantrine page.
This medicine contains important and useful components, as it consists of
Artemether + Lumefantrine is available in the market in concentration.

Generic Name of Artemether + Lumefantrine - Learn More

Artemether + Lumefantrine Precaution - What You Need to Know

The combination of Artemether and Lumefantrine is a widely used treatment for uncomplicated Plasmodium falciparum malaria. However, certain precautions must be observed to ensure safety and efficacy:
- *Severe Malaria*: This medication is not suitable for treating severe or complicated malaria cases. In such scenarios, intravenous artesunate or other parenteral antimalarials are required, along with hospitalization.
- *Pregnancy and Breastfeeding*: While the drug is classified as Pregnancy Category B, its use during pregnancy should be carefully evaluated, especially in the first trimester, due to potential risks to the fetus. For breastfeeding mothers, limited data exists on the excretion of these compounds in breast milk, so caution is advised.
- *Cardiovascular Effects*: Both Artemether and Lumefantrine can prolong the QT interval, increasing the risk of arrhythmias. Patients with pre-existing heart conditions, electrolyte imbalances, or those taking other QT-prolonging drugs should be closely monitored.
- *Drug Resistance*: To minimize the development of drug-resistant malaria strains, it is crucial to adhere strictly to the prescribed regimen and complete the full course of treatment. Overuse or misuse can contribute to resistance.

Artemether + Lumefantrine Indication - Uses and Benefits

Artemether + Lumefantrine is primarily indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum. Key indications include:
- *Uncomplicated Falciparum Malaria*: This combination effectively reduces parasitemia and prevents recrudescence due to the synergistic action of both components. It is particularly useful in regions where chloroquine resistance is prevalent.
- *Travelers Returning from Endemic Areas*: Individuals who contract malaria while traveling to high-risk regions benefit significantly from this treatment. Early diagnosis and prompt initiation of therapy are critical to prevent progression to severe disease.
- *Children and Adults*: The combination is available in various formulations tailored for different age groups and body weights, ensuring accessibility across populations. Proper dosing according to weight ensures optimal therapeutic outcomes.

Artemether + Lumefantrine Contraindications - Important Warnings

Certain conditions and scenarios contraindicate the use of Artemether + Lumefantrine:
- *Known Allergy to Artemisinins or Aminoalcohols*: Patients with hypersensitivity to either Artemether, Lumefantrine, or related compounds should avoid this medication. Signs of allergy include rash, itching, swelling, and difficulty breathing.
- *Severe Liver Disease*: Both Artemether and Lumefantrine undergo extensive hepatic metabolism. Their use in patients with severe liver impairment is contraindicated due to the risk of accumulation and toxicity. Alternative treatments should be considered in such cases.
- *Concomitant Use with Rifampicin*: Rifampicin accelerates the metabolism of both drugs, significantly reducing their plasma concentrations and efficacy. Co-administration is discouraged unless no alternatives exist, and close monitoring is implemented.

Artemether + Lumefantrine Side Effects - What to Expect

Common side effects associated with Artemether + Lumefantrine include:
- *Gastrointestinal Disturbances*: Nausea, vomiting, diarrhea, and abdominal pain are frequent during treatment. These symptoms are usually mild and transient but can sometimes necessitate supportive measures like antiemetics or rehydration therapy.
- *Headache and Dizziness*: Central nervous system effects such as headache and dizziness are common, likely due to the rapid killing of parasites and subsequent release of toxins. Rest and symptomatic treatment help manage these issues.
- *Elevated Liver Enzymes*: Transient elevations in liver function tests have been reported, though they typically resolve without intervention. Persistent abnormalities warrant further evaluation and possible discontinuation of the drug.

Artemether + Lumefantrine Pregnancy Category ID - Safety Information

3

Artemether + Lumefantrine Mode of Action - How It Works

Artemether belongs to the artemisinin class, characterized by its endoperoxide bridge, which reacts with heme produced during hemoglobin digestion by malaria parasites. This reaction generates free radicals that damage parasite proteins and membranes, ultimately leading to cell death. Artemether specifically targets intraerythrocytic stages of Plasmodium falciparum. Lumefantrine, an aminoalcohol derivative, inhibits parasite protein synthesis and disrupts membrane integrity, providing sustained activity against residual parasites. Together, they offer rapid clearance of parasites and prolonged protection against recrudescence.

Artemether + Lumefantrine Drug Interactions - What to Avoid

Several drug interactions can alter the pharmacokinetics and safety profile of Artemether + Lumefantrine:
- *CYP3A4 Inducers*: Medications like rifampicin, phenytoin, and carbamazepine induce CYP3A4 enzymes, leading to decreased levels of both Artemether and Lumefantrine, reducing therapeutic effectiveness. Dose adjustments or alternative therapies might be necessary.
- *CYP3A4 Inhibitors*: Drugs such as ketoconazole, clarithromycin, and protease inhibitors inhibit CYP3A4, increasing concentrations of both compounds and the risk of adverse effects. Monitoring for toxicity and dose reduction are warranted in these situations.
- *QT-Prolonging Agents*: Combining Artemether + Lumefantrine with other medications known to prolong the QT interval (e.g., halofantrine, mefloquine) increases the likelihood of arrhythmias. Avoidance of concurrent use or careful electrocardiographic surveillance is recommended.

Artemether + Lumefantrine Adult Dose - Recommended Dosage

For adults weighing ≥35 kg, the standard regimen consists of one tablet containing 20 mg Artemether and 120 mg Lumefantrine every 8 hours for 3 days (total of 6 doses). Each dose should be taken with food to enhance absorption and efficacy.

Artemether + Lumefantrine Child Dose - Dosage for Children

Pediatric dosing of Artemether + Lumefantrine depends on body weight:
- For children weighing 5–14 kg, administer one tablet every 8 hours for 3 days.
- For children weighing 15–24 kg, give two tablets every 8 hours for 3 days.
- For children weighing 25–34 kg, provide three tablets every 8 hours for 3 days. All doses should be given with food to improve bioavailability.

Artemether + Lumefantrine Renal Dose - Dosage for Kidney Conditions

Renal impairment does not significantly affect the pharmacokinetics of Artemether + Lumefantrine, so no specific dose adjustments are required for patients with kidney dysfunction. However, renal status should still be monitored as part of routine clinical care.